Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Companion Animal Vaccines Market
Companion Animal Vaccines Market size accounted for over USD 3 billion in 2022 and is estimated to grow at 6.6% CAGR between 2023 and 2032. High disposable income and rising prevalence of zoonotic diseases has augmented the global market growth.
Pets are largely adopted in developed countries such as Germany and U.S. majorly by elderly people for companionship. For instance, in 2022, according to the American Pet Products Association (APPA), 70% of U.S. households owns a pet. Also there has been a change in drift from pet owners to pet parents that displays pets are considered as a part of the family nowadays. Thus, increasing adoption of pets accelerates demand for companion animal vaccines market growth.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Companion Animal Vaccines Market Size in 2022: | USD 3 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 6.6% |
2032 Value Projection: | USD 5.9 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 392 |
Segments covered: | Vaccine Type, Animal Type, Route of Administration, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Companion animal vaccines are biological formulations developed to protect animals from bacterial, viral, and fungal infections caused by pathogens. Companion animal vaccines are considered an effective medium to prevent diseases, and aids in limiting the disease burden in pet animals. These vaccines play an anchoring role in improving the health and welfare of animals, promoting pet health, and restrict pathogenic animal to human transmission.